)
)
ProKidney Investor Relations Material
Latest events
Status Update
ProKidney
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from ProKidney Corp
Access all reports
ProKidney LP is an biotech company that develops cellular and gene therapies treatments, mainly targeting the chronic kidney disease (CKD). ProKidney LP was founded in 2015.
Key slides for ProKidney Corp
43rd Annual J.P. Morgan Healthcare Conference 2025
ProKidney Corp
Status Update
ProKidney Corp
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
PROK
Country
🇺🇸 United States